Cargando…
Lipoprotein concentration in patients requiring extracorporeal membrane oxygenation
Extracorporeal membrane oxygenation (ECMO), a relevant technology for patients with acute respiratory distress syndrome (ARDS) or acute cardiac failure (ACF), is a frequent cause of systemic inflammatory response syndrome. During sepsis, HDL cholesterol (HDL-C) and LDL cholesterol (LDL-C) concentrat...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390666/ https://www.ncbi.nlm.nih.gov/pubmed/34446802 http://dx.doi.org/10.1038/s41598-021-96728-3 |
_version_ | 1783743125093613568 |
---|---|
author | Tanaka, Sébastien De Tymowski, Christian Zappella, Nathalie Snauwaert, Aurélie Robert, Tiphaine Lortat-Jacob, Brice Castier, Yves Tran-Dinh, Alexy Tashk, Parvine Bouzid, Donia Para, Marylou Pellenc, Quentin Atchade, Enora Meilhac, Olivier Montravers, Philippe |
author_facet | Tanaka, Sébastien De Tymowski, Christian Zappella, Nathalie Snauwaert, Aurélie Robert, Tiphaine Lortat-Jacob, Brice Castier, Yves Tran-Dinh, Alexy Tashk, Parvine Bouzid, Donia Para, Marylou Pellenc, Quentin Atchade, Enora Meilhac, Olivier Montravers, Philippe |
author_sort | Tanaka, Sébastien |
collection | PubMed |
description | Extracorporeal membrane oxygenation (ECMO), a relevant technology for patients with acute respiratory distress syndrome (ARDS) or acute cardiac failure (ACF), is a frequent cause of systemic inflammatory response syndrome. During sepsis, HDL cholesterol (HDL-C) and LDL cholesterol (LDL-C) concentrations decrease, and an association between low lipoprotein levels and poor outcomes was reported. There are no data from patients undergoing ECMO. The goal of this study was to characterize the lipoprotein profiles of ICU patients requiring ECMO. All consecutive patients admitted for ARDS or ACF requiring ECMO were prospectively included. Daily lipoprotein levels and short-term prognosis outcome were assessed. 25 patients were included. On admission, lipoprotein concentrations were low, under the reference values ([HDL-C] = 0.6[0.4–0.8]mmol/L;[LDL-C] = 1.3[1.0–1.7]mmol/L). A statistically significant rise in lipoproteins overtime was observed during the ICU stay. We found no relationship between lipoproteins concentrations and mortality on Day-28 (p = 0.689 and p = 0.979, respectively). Comparison of surviving patients with non-surviving patients did not reveal any differences in lipoproteins concentrations. Stratification between septic and non-septic patients demonstrated that septic patients had lower lipoproteins concentrations on admission (HDL-C: 0.5[0.3–0.6]mmol/l vs 0.8[0.6–0.9]mmol/l, p = 0.003; LDL-C: 1.1[0.9–1.5]mmol/l vs 1.5[1.3–2.6]mmol/l; p = 0.012), whereas these two groups were comparable in terms of severity and outcomes. HDL-C concentrations during ICU hospitalization were also significantly lower in the septic group than in the non-septic group (p = 0.035). In conclusion, Lipoprotein concentrations are low in patients requiring ECMO but are not associated with poor outcomes. The subpopulation of septic patients had lower lipoprotein levels overtime, which reinforces the potential key-role of these particles during sepsis. |
format | Online Article Text |
id | pubmed-8390666 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-83906662021-09-01 Lipoprotein concentration in patients requiring extracorporeal membrane oxygenation Tanaka, Sébastien De Tymowski, Christian Zappella, Nathalie Snauwaert, Aurélie Robert, Tiphaine Lortat-Jacob, Brice Castier, Yves Tran-Dinh, Alexy Tashk, Parvine Bouzid, Donia Para, Marylou Pellenc, Quentin Atchade, Enora Meilhac, Olivier Montravers, Philippe Sci Rep Article Extracorporeal membrane oxygenation (ECMO), a relevant technology for patients with acute respiratory distress syndrome (ARDS) or acute cardiac failure (ACF), is a frequent cause of systemic inflammatory response syndrome. During sepsis, HDL cholesterol (HDL-C) and LDL cholesterol (LDL-C) concentrations decrease, and an association between low lipoprotein levels and poor outcomes was reported. There are no data from patients undergoing ECMO. The goal of this study was to characterize the lipoprotein profiles of ICU patients requiring ECMO. All consecutive patients admitted for ARDS or ACF requiring ECMO were prospectively included. Daily lipoprotein levels and short-term prognosis outcome were assessed. 25 patients were included. On admission, lipoprotein concentrations were low, under the reference values ([HDL-C] = 0.6[0.4–0.8]mmol/L;[LDL-C] = 1.3[1.0–1.7]mmol/L). A statistically significant rise in lipoproteins overtime was observed during the ICU stay. We found no relationship between lipoproteins concentrations and mortality on Day-28 (p = 0.689 and p = 0.979, respectively). Comparison of surviving patients with non-surviving patients did not reveal any differences in lipoproteins concentrations. Stratification between septic and non-septic patients demonstrated that septic patients had lower lipoproteins concentrations on admission (HDL-C: 0.5[0.3–0.6]mmol/l vs 0.8[0.6–0.9]mmol/l, p = 0.003; LDL-C: 1.1[0.9–1.5]mmol/l vs 1.5[1.3–2.6]mmol/l; p = 0.012), whereas these two groups were comparable in terms of severity and outcomes. HDL-C concentrations during ICU hospitalization were also significantly lower in the septic group than in the non-septic group (p = 0.035). In conclusion, Lipoprotein concentrations are low in patients requiring ECMO but are not associated with poor outcomes. The subpopulation of septic patients had lower lipoprotein levels overtime, which reinforces the potential key-role of these particles during sepsis. Nature Publishing Group UK 2021-08-26 /pmc/articles/PMC8390666/ /pubmed/34446802 http://dx.doi.org/10.1038/s41598-021-96728-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Tanaka, Sébastien De Tymowski, Christian Zappella, Nathalie Snauwaert, Aurélie Robert, Tiphaine Lortat-Jacob, Brice Castier, Yves Tran-Dinh, Alexy Tashk, Parvine Bouzid, Donia Para, Marylou Pellenc, Quentin Atchade, Enora Meilhac, Olivier Montravers, Philippe Lipoprotein concentration in patients requiring extracorporeal membrane oxygenation |
title | Lipoprotein concentration in patients requiring extracorporeal membrane oxygenation |
title_full | Lipoprotein concentration in patients requiring extracorporeal membrane oxygenation |
title_fullStr | Lipoprotein concentration in patients requiring extracorporeal membrane oxygenation |
title_full_unstemmed | Lipoprotein concentration in patients requiring extracorporeal membrane oxygenation |
title_short | Lipoprotein concentration in patients requiring extracorporeal membrane oxygenation |
title_sort | lipoprotein concentration in patients requiring extracorporeal membrane oxygenation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390666/ https://www.ncbi.nlm.nih.gov/pubmed/34446802 http://dx.doi.org/10.1038/s41598-021-96728-3 |
work_keys_str_mv | AT tanakasebastien lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation AT detymowskichristian lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation AT zappellanathalie lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation AT snauwaertaurelie lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation AT roberttiphaine lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation AT lortatjacobbrice lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation AT castieryves lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation AT trandinhalexy lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation AT tashkparvine lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation AT bouziddonia lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation AT paramarylou lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation AT pellencquentin lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation AT atchadeenora lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation AT meilhacolivier lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation AT montraversphilippe lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation |